Table 4.
Frequency of detection (%) and percentile concentrations (ng/mL) of select PFAS in paired human serum and urine (n=50).a
| Serumb | Urinec | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PFHpA | PFOA | Sb-PFOA | PFNA | PFDA | PFUnDA | PFHxS | PFHpS | n-PFOS | Sm-PFOS | MeFOSAA | PFBA | |
| Frequency (%) | 2 | 98 | 2 | 100 | 40 | 8 | 92 | 96 | 98 | 86 | 42 | 56 |
| median | <LOD | 0. 7 | <LOD | 0.5 | <LOD | <LOD | 0.5 | 0.3 | 1.7 | 0.7 | <LOD | 0.2 |
| 75th percentile | <LOD | 1.3 | <LOD | 0.7 | 0.1 | <LOD | 0.9 | 0.4 | 3.1 | 1.2 | 0.2 | 0.3 |
| 90th percentile | <LOD | 2.0 | <LOD | 1.0 | 0.2 | <LOD | 1.2 | 0.7 | 5.0 | 2.1 | 0.3 | 0.5 |
| 95th percentile | <LOD | 2.4 | <LOD | 1.2 | 0.3 | 0.1 | 1.7 | 0.8 | 5.1 | 2.3 | 0.4 | 0.6 |
| Maximum | 0.1 | 4.0 | 0.1 | 1.3 | 0.6 | 0.2 | 2.0 | 1.0 | 10.3 | 4.4 | 0.5 | 0.8 |
LODs were 0.1 ng/mL in urine and serum for all analytes.
PFBA, PFPeA, PFHxA, PFBS, PFPrS, HFPO-DA, DONA, EtFOSAA, FOSA, and 9Cl-PF3ONS were not detected in any serum samples.
Only PFBA was detected in urine